Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Odermatt

Showing results (91-100 of 220) with videos related to

Pageof 22
Sort By:
Journal of Medicinal Chemistry|June 7, 2008
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound librariesDaniela Schuster, Lyubomir G Nashev, Johannes Kirchmair, et al.
Bioanalysis|May 18, 2016
Development and characterization of a pseudo multiple reaction monitoring method for the quantification of human uromodulin in urineThomas G Hammond, Suzette Moes, Sonia Youhanna, et al.
Plos One|October 30, 2008
Dibutyltin disrupts glucocorticoid receptor function and impairs glucocorticoid-induced suppression of cytokine productionChristel Gumy, Charlie Chandsawangbhuwana, Anna A Dzyakanchuk, et al.
Journal of Lipid Research|August 13, 2013
Impaired oxidoreduction by 11β-hydroxysteroid dehydrogenase 1 results in the accumulation of 7-oxolithocholic acidCarlos A Penno, Stuart A Morgan, Anna Vuorinen, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2017
Phenylbenzenesulfonates and -sulfonamides as 17β-hydroxysteroid dehydrogenase type 2 inhibitors: Synthesis and SAR-analysisAnna Vuorinen, Roger T Engeli, Susanne Leugger, et al.
Journal of the American Society of Nephrology : JASN|February 7, 2001
Identification of receptor ligands by screening phage-display peptide libraries ex vivo on microdissected kidney tubulesAlex Odermatt, Annette Audigé, Christoph Frick, et al.
Journal of Medicinal Chemistry|June 9, 2006
The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screeningDaniela Schuster, Evelyne M Maurer, Christian Laggner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 28, 2013
Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1Arne Meyer, Anna Vuorinen, Agnieszka E Zielinska, et al.
Archives of Toxicology|October 14, 2016
IGF-1 prevents simvastatin-induced myotoxicity in C2C12 myotubesAnnalisa Bonifacio, Gerda M Sanvee, Karin Brecht, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 26, 2012
The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivationCornelia Fürstenberger, Anna Vuorinen, Thierry Da Cunha, et al.
Pageof 22

Showing results (91-100 of 220) with videos related to

Sort By:
Pageof 22
Journal of Medicinal Chemistry|June 7, 2008
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound librariesDaniela Schuster, Lyubomir G Nashev, Johannes Kirchmair, et al.
Bioanalysis|May 18, 2016
Development and characterization of a pseudo multiple reaction monitoring method for the quantification of human uromodulin in urineThomas G Hammond, Suzette Moes, Sonia Youhanna, et al.
Plos One|October 30, 2008
Dibutyltin disrupts glucocorticoid receptor function and impairs glucocorticoid-induced suppression of cytokine productionChristel Gumy, Charlie Chandsawangbhuwana, Anna A Dzyakanchuk, et al.
Journal of Lipid Research|August 13, 2013
Impaired oxidoreduction by 11β-hydroxysteroid dehydrogenase 1 results in the accumulation of 7-oxolithocholic acidCarlos A Penno, Stuart A Morgan, Anna Vuorinen, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2017
Phenylbenzenesulfonates and -sulfonamides as 17β-hydroxysteroid dehydrogenase type 2 inhibitors: Synthesis and SAR-analysisAnna Vuorinen, Roger T Engeli, Susanne Leugger, et al.
Journal of the American Society of Nephrology : JASN|February 7, 2001
Identification of receptor ligands by screening phage-display peptide libraries ex vivo on microdissected kidney tubulesAlex Odermatt, Annette Audigé, Christoph Frick, et al.
Journal of Medicinal Chemistry|June 9, 2006
The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screeningDaniela Schuster, Evelyne M Maurer, Christian Laggner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 28, 2013
Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1Arne Meyer, Anna Vuorinen, Agnieszka E Zielinska, et al.
Archives of Toxicology|October 14, 2016
IGF-1 prevents simvastatin-induced myotoxicity in C2C12 myotubesAnnalisa Bonifacio, Gerda M Sanvee, Karin Brecht, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 26, 2012
The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivationCornelia Fürstenberger, Anna Vuorinen, Thierry Da Cunha, et al.
Pageof 22